Ondine Biomedical, Inc. ( (GB:OBI) ) just unveiled an announcement.
Ondine Biomedical Inc., a company in the biotechnology sector, has issued new shares leading to a dilution of ownership. This change has impacted Carolyn Cross, a major shareholder, whose voting rights have decreased from 29.23% to 26.71%, indicating a significant shift in the company’s shareholder structure.
More about Ondine Biomedical, Inc.
YTD Price Performance: 31.43%
Average Trading Volume: 528,037
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £48.48M
Find detailed analytics on OBI stock on TipRanks’ Stock Analysis page.